1. Home
  2. CING vs GSIW Comparison

CING vs GSIW Comparison

Compare CING & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • GSIW
  • Stock Information
  • Founded
  • CING 2012
  • GSIW 2016
  • Country
  • CING United States
  • GSIW Hong Kong
  • Employees
  • CING N/A
  • GSIW N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • GSIW
  • Sector
  • CING Health Care
  • GSIW
  • Exchange
  • CING Nasdaq
  • GSIW Nasdaq
  • Market Cap
  • CING 13.1M
  • GSIW 12.3M
  • IPO Year
  • CING 2021
  • GSIW 2023
  • Fundamental
  • Price
  • CING $4.16
  • GSIW $0.48
  • Analyst Decision
  • CING Strong Buy
  • GSIW
  • Analyst Count
  • CING 3
  • GSIW 0
  • Target Price
  • CING $16.00
  • GSIW N/A
  • AVG Volume (30 Days)
  • CING 78.2K
  • GSIW 91.3K
  • Earning Date
  • CING 05-07-2025
  • GSIW 12-31-2024
  • Dividend Yield
  • CING N/A
  • GSIW N/A
  • EPS Growth
  • CING N/A
  • GSIW N/A
  • EPS
  • CING N/A
  • GSIW N/A
  • Revenue
  • CING N/A
  • GSIW $1,313,795.00
  • Revenue This Year
  • CING $82.10
  • GSIW N/A
  • Revenue Next Year
  • CING N/A
  • GSIW N/A
  • P/E Ratio
  • CING N/A
  • GSIW N/A
  • Revenue Growth
  • CING N/A
  • GSIW N/A
  • 52 Week Low
  • CING $1.80
  • GSIW $0.43
  • 52 Week High
  • CING $20.83
  • GSIW $12.30
  • Technical
  • Relative Strength Index (RSI)
  • CING 52.65
  • GSIW 47.04
  • Support Level
  • CING $3.95
  • GSIW $0.45
  • Resistance Level
  • CING $4.44
  • GSIW $0.52
  • Average True Range (ATR)
  • CING 0.27
  • GSIW 0.03
  • MACD
  • CING 0.07
  • GSIW 0.00
  • Stochastic Oscillator
  • CING 66.89
  • GSIW 58.82

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: